Belmontesi Magda
J Drugs Dermatol. 2025 Jan 1;24(1):88-94. doi: 10.36849/JDD.8877.
Acne is prevalent in approximately 80% of individuals aged 11 to 30 years, with scarring occurring in about 40% of cases. Early and sustained treatment is crucial for preventing acne scarring, regardless of severity.
The objective of this study was to evaluate skin tolerability and patient compliance after combining a specific dermatologic routine with pharmacological therapy in patients affected by different degrees of acne.
A comprehensive treatment approach was developed, combining pharmacological therapies in line with established guidelines and a supportive dermocosmetic routine. This routine included a gentle soap-free cleansing emulsion, a moisturizing cream containing glycerin, niacinamide, panthenol, and photoprotection. An anonymous questionnaire was administered to 28 patients (ages 14-31, male and female) to assess their satisfaction and adherence to the treatment plan.
Patient adherence to the therapeutic protocol was found to be essential for achieving expected outcomes. The integration of a specific dermocosmetic routine significantly reduced the risks of erythema, dryness, sensitivity, and retinoid dermatitis, which can lead to treatment interruption and failure. The majority of patients reported high levels of satisfaction with the dermocosmetic products, reinforcing their role in supporting pharmacological treatment.
A holistic approach that integrates personalized dermocosmetological prescription to support pharmacological treatment in the different degrees of acne severity significantly enhances patient adherence and satisfaction, which is essential for successful acne management. By prioritizing adherence to treatment protocols and supporting them with an effective dermocosmetic routine, this strategy ensures better overall outcomes in managing acne. J Drugs Dermatol. 2025;24(1):88-94. doi:10.36849/JDD.8877.
